Farmak pharmaceutical company (Kyiv) plans to invest UAH 1.2 billion in production development in 2020, which is 30% more than last year, and also increase the number of staff. According to the company’s press service, with reference to executive director of Farmak Volodymyr Kostiuk, in 2019 investments for these purposes amounted to UAH 900 million.
“In 2019, we invested about UAH 900 million in the development of production, in 2020 we plan to invest UAH 1.2 billion. The expansion of production leads to an increase in the number of personnel,” he said.
According to Kostiuk, the issue of personnel remains acute for the company.
“We create the most comfortable working conditions for specialists and provide competitive wages. Today we compete with European companies in terms of wages in relation to the average check in a particular country. In 2019, wages at Farmak increased by 14%,” he said.
The top manager also said that in 2019 Farmak expanded its cold, allergological, neurological, gastroenterological product portfolios and is working on complex drugs that it plans to bring to the market in 10-15 years.
The main areas remain cold, endocrinological, gastroenterological, cardiological, neurological portfolios.
